014420000a22003370004500003000900000005001700009110018300026245029100209562002100500264004900521300000900570041000800579650006300587650005600650650004400706650003100750650001800781651001400799650001600813650001200829651001200841651001000853650001200863651001000875651001300885650001200898650001200910651003200922700004000954700011000994PH-MaWHO20241108112245.0  aWHO Consultation on Clinical and Neuropathological Characteristics of the New Variant of CJD and other Human and Animal Transmissible Spongiform Encephalopathies (1996 : Geneva).  aReport of a WHO Consultation on Clinical and Neuropathological Characteristics of the New Variant of CJD and other Human and Animal Transmissible Spongiform Encephalopathies with the participation of the Office International des Epizooties (OIE), Geneva, Switzerland, 14 to 16 May 1996.  aWHO/EMC/ZOO/96.1  aGeneva : bWorld Health Organization,c1996.  a19p.  aeng  aEncephalopathy, Bovine spongiformxPathology, transmission  aCreutzfeldt-Jakob syndromexPathology, epidemiology  aPrionsxImmunology, cytology, chemistry  aEpidemiologic surveillance  aLatin America  aAustralia  aNew Zealand  aAustria  aGermany  aIndia  aIreland  aJapan  aThailand  aTunisia  aSenegal  aAfrica, South of the Sahara  aInternational Office of Epizootics.  aWorld Health Organization. Division of Emerging and other Communicable Diseases Surveillance and Control.